Robert A. Kratzke
Expertise in
12
conditions

Dr. Robert A. Kratzke

Oncology
909 Fulton Street Southeast, 
Minneapolis, MN 
Accepting New Patients
Offers Telehealth
Expertise in
12
conditions
909 Fulton Street Southeast, 
Minneapolis, MN 

Overview

Robert Kratzke is an Oncologist practicing medicine in Minneapolis, Minnesota.

Dr. Kratzke is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Mesothelioma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Endoscopy.

Dr. Kratzke is board certified in Internal Medicine: American Board Of Internal Medicine, 1986 and Medical Oncology: American Board Of Internal Medicine, 1991. He is actively involved in clinical research, co-authoring 74 peer reviewed articles and participating in 3 clinical trials. Dr. Kratzke is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in MN

Board Certifications

Internal Medicine: American Board Of Internal Medicine, 1986
Medical Oncology: American Board Of Internal Medicine, 1991

Fellowships

National Cancer Institute, Medical Oncology - 1991
National Cancer Institute, Research - 1994

Hospital Affiliations

Fairview Lakes Health Services
M Health Fairview University Of Mn Medical Center
M Health Fairview Southdale Hospital
Fairview Northland Regional Hospital
M Health Fairview Ridges Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Group Health Cooperative
  • HMO
  • POS
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Metropolitan Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
PreferredOne
  • HMO
  • OTHER COMMERCIAL
Sanford Health
  • HMO
  • PPO
South Country Health Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

M Health Fairview Masonic Cancer Clinic
909 Fulton Street Southeast, Minneapolis, MN 55455

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure
A Phase 3, Open-Label, Randomized, Parallel Group Study to Evaluate the Efficacy and Safety of Intrapleural Administration of Adenovirus-Delivered Interferon Alpha-2b (rAd-IFN) in Combination With Celecoxib and Gemcitabine in Patients With Malignant Pleural Mesothelioma
A Phase 3, Open-Label, Randomized, Parallel Group Study to Evaluate the Efficacy and Safety of Intrapleural Administration of Adenovirus-Delivered Interferon Alpha-2b (rAd-IFN) in Combination With Celecoxib and Gemcitabine in Patients With Malignant Pleural Mesothelioma
Enrollment Status: Completed
Publish Date: April 21, 2026
Intervention Type: Biological, Drug
Study Drugs: rAd-IFN, Celecoxib, Gemcitabine
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of an Oral, Selective Peripheral Opioid Receptor Antagonist in Advanced Non-Small Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of an Oral, Selective Peripheral Opioid Receptor Antagonist in Advanced Non-Small Cell Lung Cancer
Enrollment Status: Terminated
Publish Date: July 17, 2025
Intervention Type: Other, Drug
Study Drug: Naloxegol
Study Phase: Phase 2
View 2 Less Clinical Trials

74 Total Publications

STK11 as an Emerging Biomarker in Non-Small Cell Lung Cancer.
STK11 as an Emerging Biomarker in Non-Small Cell Lung Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: March 06, 2026
Similar Doctors
Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required

M Health Fairview Masonic Cancer Clinic

909 Fulton Street Southeast, 
Minneapolis, MN 
 (0.1 miles away)
612-676-4200
Languages Spoken:
English, French, Greek
See accepted insurances
Accepting New Patients
Offers Telehealth

Emmanuel Antonarakis is an Oncologist practicing medicine in Minneapolis, Minnesota. Dr. Antonarakis is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, PIK3CA-Related Overgrowth Spectrum, Hormone Replacement Therapy (HRT), and Prostatectomy. Dr. Antonarakis is board certified in Medical Oncology: American Board Of Internal Medicine, 2009. Dr. Antonarakis is currently accepting new patients.

Expertise in
26
conditions
Expertise in
26
conditions
Referral may be required

M Health Fairview Masonic Cancer Clinic

909 Fulton Street Southeast, 
Minneapolis, MN 
 (0.1 miles away)
612-676-4200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Keith Skubitz is an Oncologist practicing medicine in Minneapolis, Minnesota. Dr. Skubitz is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Bone Tumor, Liposarcoma, Alveolar Soft Part Sarcoma, and Splenectomy. Dr. Skubitz is board certified in Medical Oncology: American Board Of Internal Medicine, 1985 and Internal Medicine: American Board Of Internal Medicine, 1979. Dr. Skubitz is currently accepting new patients.

Expertise in
9
conditions
Dr. Mukta Arora
Hematology | Oncology
Expertise in
9
conditions
Dr. Mukta Arora
Hematology | Oncology
Referral may be required

Fairview Pharmacy Services LLC

516 Delaware St SE, 
Minneapolis, MN 
 (0.1 miles away)
612-273-2800
Languages Spoken:
English
See accepted insurances

Mukta Arora is a Hematologist and an Oncologist practicing medicine in Minneapolis, Minnesota. Dr. Arora is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.

Frequently Asked Questions about Dr. Robert A. Kratzke

How do I make an appointment with Dr. Robert A. Kratzke?

You can book an appointment with Dr. Robert A. Kratzke by calling their office at 612-676-4200. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Robert A. Kratzke a top-rated expert for Mesothelioma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Robert A. Kratzke is classified as an Elite expert for Mesothelioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Robert A. Kratzke specialize in?

While Dr. Robert A. Kratzke is a Oncology, they have specific expertise in Mesothelioma, Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Robert A. Kratzke participate in research or clinical trials?

Yes. Dr. Robert A. Kratzke has published 74 articles and abstracts on conditions like Mesothelioma. You can view a list of Dr. Robert A. Kratzke's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Robert A. Kratzke accept my insurance?

Dr. Robert A. Kratzke accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 612-676-4200 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kratzke's expertise for a condition
ConditionClose
View All 19 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile